Publication | Closed Access

CT-based radiomics signatures can predict the tumor response of non-small cell lung cancer patients treated with first-line chemotherapy and targeted therapy

Tumor ResponseHealth SciencesOncologic ImagingMedicineMultiple Pulmonary NoduleBronchial NeoplasmRadiomicsLung CancerFirst-line ChemotherapyOncologyRadiation OncologyNuclear MedicineRadiologyCt-based Radiomics Signatures